BACKGROUND: To evaluate the possibility of predicting the development of doxorubicin-induced cardiomyopathy, we performed quantitative assessment of the early kinetics of iodine-123 beta-methyl-iodophenyl-pentadecanoic acid (I-123 BMIPP) by means of dynamic myocardial SPECT. METHODS: Thirty-six patients with various malignancies were examined. I-123 BMIPP dynamic myocardial SPECT was performed before chemotherapy, after chemotherapy, or both. Immediately after the injection of I-123 BMIPP (111 MBq), 30-second dynamic SPECT data were acquired successively for 15 minutes. The left ventricular (LV) myocardium was divided into 8 segments in short-axial and vertical slices. By using the time-activity curve (TAC) of each myocardial segment [Mo(t)] as an output function and the TAC of the LV cavity [B(t)] as an input function, the Rutland equation, Mo(t)/B(t)= F + K Integral of(B(t)dt/B(t)), was used as a means of assessing all segments. RESULTS: Mo(t)/B(t) showed a good linear correlation with Integral of(B(t)dt/B(t)) from 30 seconds to 4 minutes in all 456 segments. The mean K value of 8 LV segments was significantly lower after chemotherapy than before chemotherapy (0.071+/-0.019 [n = 21] vs. 0.095+/-0.025 [n = 36], P<.001). In 21 patients in whom dynamic SPECT was performed both before and after chemotherapy, the mean K values of left ventricle showed a significant decrease, from 0.101+/-0.024 to 0.071 +/-0.019 (P<.0001). The fractional change in the value of K after chemotherapy showed a significant linear correlation with the administered dose of doxorubicin (r = 0.648, P<.002). CONCLUSION: I-123 BMIPP dynamic myocardial SPECT may be clinically useful, because it permits the early detection of doxorubicin-induced cardiomyopathy.
BACKGROUND: To evaluate the possibility of predicting the development of doxorubicin-induced cardiomyopathy, we performed quantitative assessment of the early kinetics of iodine-123 beta-methyl-iodophenyl-pentadecanoic acid (I-123BMIPP) by means of dynamic myocardial SPECT. METHODS: Thirty-six patients with various malignancies were examined. I-123BMIPP dynamic myocardial SPECT was performed before chemotherapy, after chemotherapy, or both. Immediately after the injection of I-123BMIPP (111 MBq), 30-second dynamic SPECT data were acquired successively for 15 minutes. The left ventricular (LV) myocardium was divided into 8 segments in short-axial and vertical slices. By using the time-activity curve (TAC) of each myocardial segment [Mo(t)] as an output function and the TAC of the LV cavity [B(t)] as an input function, the Rutland equation, Mo(t)/B(t)= F + K Integral of(B(t)dt/B(t)), was used as a means of assessing all segments. RESULTS: Mo(t)/B(t) showed a good linear correlation with Integral of(B(t)dt/B(t)) from 30 seconds to 4 minutes in all 456 segments. The mean K value of 8 LV segments was significantly lower after chemotherapy than before chemotherapy (0.071+/-0.019 [n = 21] vs. 0.095+/-0.025 [n = 36], P<.001). In 21 patients in whom dynamic SPECT was performed both before and after chemotherapy, the mean K values of left ventricle showed a significant decrease, from 0.101+/-0.024 to 0.071 +/-0.019 (P<.0001). The fractional change in the value of K after chemotherapy showed a significant linear correlation with the administered dose of doxorubicin (r = 0.648, P<.002). CONCLUSION:I-123BMIPP dynamic myocardial SPECT may be clinically useful, because it permits the early detection of doxorubicin-induced cardiomyopathy.
Authors: Y Fujibayashi; Y Yonekura; Y Takemura; K Wada; K Matsumoto; N Tamaki; K Yamamoto; J Konishi; A Yokoyama Journal: J Nucl Med Date: 1990-11 Impact factor: 10.057
Authors: C L Maini; R Sciuto; A Ferraironi; P Vici; A Tofani; A Festa; F Conti; M Lopez Journal: J Nucl Cardiol Date: 1997 Nov-Dec Impact factor: 5.952
Authors: R Nohara; K Okuda; M Ogino; R Hosokawa; N Tamaki; J Konishi; Y Fujibayashi; Y Yonekura; M Fujita; S Sasayama Journal: J Nucl Med Date: 1996-08 Impact factor: 10.057
Authors: D D Von Hoff; M W Layard; P Basa; H L Davis; A L Von Hoff; M Rozencweig; F M Muggia Journal: Ann Intern Med Date: 1979-11 Impact factor: 25.391
Authors: E H Hwang; J Taki; S Yasue; M Fujimoto; M Taniguchi; I Matsunari; K Nakajima; S Shiobara; T Ikeda; N Tonami Journal: J Nucl Med Date: 1998-10 Impact factor: 10.057
Authors: Hein J Verberne; Christel Feenstra; W Matthijs de Jong; G Aernout Somsen; Berthe L F van Eck-Smit; Ellinor Busemann Sokole Journal: Eur J Nucl Med Mol Imaging Date: 2005-05-18 Impact factor: 9.236
Authors: Nabil E Boutagy; Jing Wu; Zhengxi Cai; Wenjie Zhang; Carmen J Booth; Tassos C Kyriakides; Daniel Pfau; Tim Mulnix; Zhao Liu; Edward J Miller; Lawrence H Young; Richard E Carson; Yiyun Huang; Chi Liu; Albert J Sinusas Journal: JACC Basic Transl Sci Date: 2018-05-30
Authors: Attila Feher; Nabil E Boutagy; John C Stendahl; Christi Hawley; Nicole Guerrera; Carmen J Booth; Eva Romito; Steven Wilson; Chi Liu; Albert J Sinusas Journal: JACC CardioOncol Date: 2020-06-16